Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 3:48 PM
Ignite Modification Date:
2025-12-25 @ 1:56 PM
NCT ID:
NCT00445692
Group ID:
EG000
Title:
Treatment (Clarithromycin, Dexamethasone, Lenalidomide)
Description:
Patients receive clarithromycin orally (PO) twice daily and dexamethasone PO once a week. Treatment with clarithromycin and dexamethasone continues for up to 1 year in the absence of disease progression or unacceptable toxicity. Patients also receive lenalidomide PO once daily on days 1-14. Courses with lenalidomide repeat every 21 days in the absence of disease progression or unacceptable toxicity. Lenalidomide is taken 4 hours or more after last dose of daily clarithromycin.
NOTE: \*After one year of treatment, dexamethasone is tapered for an additional 4 weeks.
Clarithromycin: Given Orally (PO)
Dexamethasone: Given PO
Lenalidomide: Given PO
Deaths Number Affected:
13
Deaths Number At Risk:
None
Serious Number Affected:
11
Serious Number At Risk:
31
Other Number Affected:
19
Other Number At Risk:
31
Study:
NCT00445692
Results Section:
NCT00445692
Adverse Events Module:
NCT00445692